TB – IGRA
PHRI developed M. tuberculosis-specific reagents utilized in Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection.
PHRI developed the molecular beacon technology that is used in the Cepheid Xpert MTB/RIF assay to diagnose active tuberculosis, including some forms of antibiotic-resistant tuberculosis.
Fujifilm SILVAMP TB LAM
PHRI developed reagents utilized in the most recent version of the assay detecting M. tuberculosis LAM (lipoarabinomannan) in the urine of people having active tuberculosis. To read more, follow this link.